SDC4 Gene Silencing Favors Human Papillary Thyroid Carcinoma Cell Apoptosis and Inhibits Epithelial Mesenchymal Transition via Wnt/β-Catenin Pathway |
Chen, Liang-Liang
(Department of Surgical Oncology, Ningbo No.2 Hospital)
Gao, Ge-Xin (School of Nursing, Wenzhou Medical University) Shen, Fei-Xia (Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University) Chen, Xiong (Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University) Gong, Xiao-Hua (Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University) Wu, Wen-Jun (Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University) |
1 | Yao, H., Ashihara, E., and Maekawa, T. (2011). Targeting the Wnt/-catenin signaling pathway in human cancers. Expert Opin. Ther. Targets 15, 873-887. DOI |
2 | Zhang, J., Gill, A.J., Issacs, J.D., Atmore, B., Johns, A., Delbridge, L.W., Lai, R., and McMullen, T.P. (2012). The Wnt/-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer. Hum. Pathol. 43, 1044-1050. DOI |
3 | Zhang, X., Li, M., Zuo, K., Li, D., Ye, M., Ding, L., Cai, H., Fu, D., Fan, Y., and Lv, Z. (2013). Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/-catenin signaling. J. Clin. Endocrinol. Metabol. 98, E1305-1313. DOI |
4 | Zhong, H., De Marzo, A.M., Laughner, E., Lim, M., Hilton, D.A., Zagzag, D., Buechler, P., Isaacs, W.B., Semenza, G.L., and Simons, J.W. (1999). Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 59, 5830-5835. |
5 | Bai, D., Sun, H., Wang, X., Lou, H., Zhang, J., Wang, X., and Jiang, L. (2017). MiR-150 Inhibits cell growth in vitro and in vivo by restraining the RAB11A/WNT/-catenin pathway in thyroid cancer. Med. Sci. Monit. 23, 4885-4894. DOI |
6 | Brown, R.L., de Souza, J.A., and Cohen, E.E. (2011). Thyroid cancer: burden of illness and management of disease. J. Cancer 2, 193-199. DOI |
7 | Cancer Genome Atlas Research Network (2014). Integrated genomic characterization of papillary thyroid carcinoma. Cell 159, 676-690. DOI |
8 | Cho, I.R., Koh, S.S., Min, H.J., Kim, S.J., Lee, Y., Park, E.H., Ratakorn, S., Jhun, B.H., Oh, S., Johnston, R.N., et al. (2011). Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the expression of -catenin, leading to a rapid proliferation of pancreatic cells. Exp. Mol. Med. 43, 82-90. DOI |
9 | Cho, S.W., Lee, E.J., Kim, H., Kim, S.H., Ahn, H.Y., Kim, Y.A., Yi, K.H., Park, D.J., Shin, C.S., Ahn, S.H., et al. (2013). Dickkopf-1 inhibits thyroid cancer cell survival and migration through regulation of -catenin/E-cadherin signaling. Mol. Cell. Endocrinol. 366, 90-98. DOI |
10 | Chung, K.W., Kim, S.W., and Kim, S.W. (2012). Gene expression profiling of papillary thyroid carcinomas in Korean patients by oligonucleotide microarrays. J. Korean Surg. Soc. 82, 271-280. DOI |
11 | Czabotar, P.E., Westphal, D., Dewson, G., Ma, S., Hockings, C., Fairlie, W.D., Lee, E.F., Yao, S., Robin, A.Y., Smith, B.J., et al. (2013). Bax crystal structures reveal how BH3 domains activate Bax and nucleate its oligomerization to induce apoptosis. Cell 152, 519-531. DOI |
12 | Da, C., Wu, K., Yue, C., Bai, P., Wang, R., Wang, G., Zhao, M., Lv, Y., and Hou, P. (2017). N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways. Oncotarget 8, 8131-8142. |
13 | Fujita, A., Sato, J.R., Rodrigues Lde, O., Ferreira, C.E., and Sogayar, M.C. (2006). Evaluating different methods of microarray data normalization. BMC bioinformatics 7, 469. DOI |
14 | Echtermeyer, F., Harendza, T., Hubrich, S., Lorenz, A., Herzog, C., Mueller, M., Schmitz, M., Grund, A., Larmann, J., Stypmann, J., et al. (2011). Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodelling. Cardiovasc. Res. 92, 123-131. DOI |
15 | Erdem, M., Erdem, S., Sanli, O., Sak, H., Kilicaslan, I., Sahin, F., and Telci, D. (2014). Up-regulation of TGM2 with ITGB1 and SDC4 is important in the development and metastasis of renal cell carcinoma. Urol. Oncol. 32, 25 e13-20. DOI |
16 | Francis, G.L., Waguespack, S.G., Bauer, A.J., Angelos, P., Benvenga, S., Cerutti, J.M., Dinauer, C.A., Hamilton, J., Hay, I.D., Luster, M., et al. (2015). Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 25, 716-759. DOI |
17 | Gilbert-Sirieix, M., Makoukji, J., Kimura, S., Talbot, M., Caillou, B., Massaad, C., and Massaad-Massade, L. (2011). Wnt/-catenin signaling pathway is a direct enhancer of thyroid transcription factor-1 in human papillary thyroid carcinoma cells. PloS one 6, e22280. DOI |
18 | Hellmann, F., Verdi, M., Schlemper, B.R., Jr., and Caponi, S. (2014). 50th anniversary of the declaration of Helsinki: the double standard was introduced. Arch. Med. Res. 45, 600-601. DOI |
19 | Jung, C.K., Little, M.P., Lubin, J.H., Brenner, A.V., Wells, S.A., Jr., Sigurdson, A.J., and Nikiforov, Y.E. (2014). The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations. J. Clin. Endocrinol. Metab. 99, E276-285. DOI |
20 | Huang, J., Xiao, D., Li, G., Ma, J., Chen, P., Yuan, W., Hou, F., Ge, J., Zhong, M., Tang, Y., et al. (2014). EphA2 promotes epithelialmesenchymal transition through the Wnt/-catenin pathway in gastric cancer cells. Oncogene 33, 2737-2747. DOI |
21 | Lee, M.A., Park, J.H., Rhyu, S.Y., Oh, S.T., Kang, W.K., and Kim, H.N. (2014). Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer. BMC Cancer 14, 125. DOI |
22 | Lendorf, M.E., Manon-Jensen, T., Kronqvist, P., Multhaupt, H.A., and Couchman, J.R. (2011). Syndecan-1 and syndecan-4 are independent indicators in breast carcinoma. J. Histochem. Cytochem. 59, 615-629. DOI |
23 | Li, X., Abdel-Mageed, A.B., and Kandil, E. (2012). BRAF mutation in papillary thyroid carcinoma. Int. J. Clin. Exp. Med. 5, 310-315. |
24 | Liu, W., Chen, Y., Xie, H., Guo, Y., Ren, D., Li, Y., Jing, X., Li, D., Wang, X., Zhao, M., et al. (2018). TIPE1 suppresses invasion and migration through down-regulating Wnt/-catenin pathway in gastric cancer. J. Cell. Mol. Med. 22, 1103-1117. |
25 | Looyenga, B.D., Furge, K.A., Dykema, K.J., Koeman, J., Swiatek, P.J., Giordano, T.J., West, A.B., Resau, J.H., Teh, B.T., and MacKeigan, J.P. (2011). Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas. Proc. Natl. Acad. Sci. USA 108, 1439-1444. DOI |
26 | Ohkawara, B., Glinka, A., and Niehrs, C. (2011). Rspo3 binds syndecan 4 and induces Wnt/PCP signaling via clathrin-mediated endocytosis to promote morphogenesis. Dev. Cell 20, 303-314. DOI |
27 | Lu, T., Bao, Z., Wang, Y., Yang, L., Lu, B., Yan, K., Wang, S., Wei, H., Zhang, Z., and Cui, G. (2016). Karyopherin1 regulates proliferation of human glioma cells via Wnt/-catenin pathway. Biochem. Biophys. Res. Commun. 478, 1189-1197. DOI |
28 | Lv, N., Shan, Z., Gao, Y., Guan, H., Fan, C., Wang, H., and Teng, W. (2016). Twist1 regulates the epithelial-mesenchymal transition via the NF-kappaB pathway in papillary thyroid carcinoma. Endocrine 51, 469-477. DOI |
29 | Ma, L., Young, J., Prabhala, H., Pan, E., Mestdagh, P., Muth, D., Teruya-Feldstein, J., Reinhardt, F., Onder, T.T., Valastyan, S., et al. (2010). miR-9, a MYC/MYCN-activated microRNA, regulates Ecadherin and cancer metastasis. Nat. Cell Biol. 12, 247-256. DOI |
30 | Nikolova, V., Koo, C.Y., Ibrahim, S.A., Wang, Z., Spillmann, D., Dreier, R., Kelsch, R., Fischgrabe, J., Smollich, M., Rossi, L.H., et al. (2009). Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression. Carcinogenesis 30, 397-407. DOI |
31 | Ohori, N.P., Wolfe, J., Carty, S.E., Yip, L., LeBeau, S.O., Berg, A.N., Schoedel, K.E., Nikiforov, Y.E., and Seethala, R.R. (2017). The influence of the noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) resection diagnosis on the falsepositive thyroid cytology rate relates to quality assurance thresholds and the application of NIFTP criteria. Cancer Cytopathol. 125, 692-700. DOI |
32 | Okolicsanyi, R.K., Buffiere, A., Jacinto, J.M., Chacon-Cortes, D., Chambers, S.K., Youl, P.H., Haupt, L.M., and Griffiths, L.R. (2015). Association of heparan sulfate proteoglycans SDC1 and SDC4 polymorphisms with breast cancer in an Australian Caucasian population. Tumour Biol. 36, 1731-1738. DOI |
33 | Vuoriluoto, K., Haugen, H., Kiviluoto, S., Mpindi, J.P., Nevo, J., Gjerdrum, C., Tiron, C., Lorens, J.B., and Ivaska, J. (2011). Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 30, 1436-1448. DOI |
34 | Sheu, S.Y., Grabellus, F., Schwertheim, S., Worm, K., Broecker-Preuss, M., and Schmid, K.W. (2010). Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours. Br. J. Cancer 102, 376-382. DOI |
35 | Skommer, J., Brittain, T., and Raychaudhuri, S. (2010). Bcl-2 inhibits apoptosis by increasing the time-to-death and intrinsic cell-to-cell variations in the mitochondrial pathway of cell death. Apoptosis 15, 1223-1233. DOI |
36 | Smyth, G.K. (2004). Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3. |
37 | Tanaka, H., Kono, E., Tran, C.P., Miyazaki, H., Yamashiro, J., Shimomura, T., Fazli, L., Wada, R., Huang, J., Vessella, R.L., et al. (2010). Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nat. Med. 16, 1414-1420. DOI |
38 | Toba-Ichihashi, Y., Yamaoka, T., Ohmori, T., and Ohba, M. (2016). Up-regulation of Syndecan-4 contributes to TGF-1-induced epithelial to mesenchymal transition in lung adenocarcinoma A549 cells. Biochem. Biophys. Rep. 5, 1-7. |
39 | Wang, X., Lu, X., Geng, Z., Yang, G., and Shi, Y. (2017). LncRNA PTCSC3/miR-574-5p governs cell proliferation and migration of papillary thyroid carcinoma via Wnt/-catenin signaling. J. Cell. Biochem. 118, 4745-4752. DOI |
40 | Astudillo, P., and Larrain, J. (2014). Wnt signaling and cell-matrix adhesion. Curr. Mol. Med. 14, 209-220. DOI |
41 | Astudillo, P., Carrasco, H., and Larrain, J. (2014). Syndecan-4 inhibits Wnt/-catenin signaling through regulation of low-densitylipoprotein receptor-related protein (LRP6) and R-spondin 3. Int. J. Biochem. Cell Biol. 46, 103-112. DOI |
42 | Xu, B., and Ghossein, R. (2018). Evolution of the histologic classification of thyroid neoplasms and its impact on clinical management. Eur. J. Surg. Oncol. 44, 338-347. DOI |
43 | Xing, M., Alzahrani, A.S., Carson, K.A., Viola, D., Elisei, R., Bendlova, B., Yip, L., Mian, C., Vianello, F., Tuttle, R.M., et al. (2013). Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA 309, 1493-1501. DOI |